Axial Pattern Flaps

Axial pattern flaps are pedicled skin flaps that incorporate a direct cutaneous artery and vein, allowing for the transfer of a large island of skin with a robust, independent blood supply. These flaps are a cornerstone of reconstructive surgery in veterinary medicine, enabling the closure of extensive skin defects that would otherwise be impossible to manage with simple closure or skin grafts. The term 'axial' refers to the presence of a named, anatomically consistent vascular pedicle that runs along the long axis of the flap, providing superior perfusion compared to random pattern flaps, which rely on the subdermal plexus. Axial pattern flaps are classified based on the specific artery and vein included, such as the thoracodorsal, caudal superficial epigastric, omocervical, superficial cervical, lateral thoracic, deep circumflex iliac, cranial superficial epigastric, and genicular flaps. These flaps are typically elevated as island flaps, where the skin is incised circumferentially, leaving only the vascular pedicle attached, or as advancement flaps, where the skin is partially incised and advanced into the defect. The choice of flap depends on the location and size of the defect, the availability of donor tissue, and the patient's conformation. Axial pattern flaps are widely used in oncologic surgery, trauma reconstruction, and correction of congenital deformities, providing a reliable method for achieving primary wound closure with excellent cosmetic and functional outcomes.

The primary indication for axial pattern flaps is the reconstruction of large skin defects resulting from various etiologies. These include: 1) Traumatic injuries: severe lacerations, avulsions, degloving injuries, and burn wounds that result in extensive skin loss, particularly on the distal extremities, trunk, and head. 2) Neoplastic disease: surgical excision of malignant or benign tumors with wide margins, such as mast cell tumors, soft tissue sarcomas, fibrosarcomas, and squamous cell carcinomas, often leaving large defects that cannot be closed primarily. 3) Congenital anomalies: rare conditions such as dermoid sinuses or skin aplasia that require surgical correction. 4) Iatrogenic causes: complications from previous surgeries, including wound dehiscence, infection, or excessive tension during closure, leading to skin necrosis. 5) Degenerative conditions: chronic non-healing wounds, pressure sores, or radiation-induced skin damage. The underlying pathophysiology involves the loss of skin integrity and vascularity, necessitating a reconstructive approach that provides both coverage and a reliable blood supply to promote healing and prevent infection.

Axial pattern flaps are utilized in both canine and feline patients, with no specific breed or sex predilection. However, certain breeds may be overrepresented due to a higher incidence of tumors requiring wide excision, such as Boxers, Golden Retrievers, and Labrador Retrievers for mast cell tumors and soft tissue sarcomas. Age distribution reflects the oncologic and traumatic etiologies, with middle-aged to older animals (7-12 years) commonly affected by neoplasia, while younger animals may present with traumatic injuries. Working dogs, such as hunting and police dogs, may have a higher risk of traumatic skin defects. The incidence of axial pattern flap use is not well-documented, but it is a standard procedure in veterinary referral centers. Anatomical variations, such as the availability of specific donor sites, can influence flap selection; for example, the caudal superficial epigastric flap is commonly used in female dogs due to the abundant skin in the caudal abdominal region, while the thoracodorsal flap is versatile for defects on the thoracic and forelimb regions.

The success of axial pattern flaps relies on the preservation of the direct cutaneous artery and vein, which provide a high-pressure, low-resistance blood supply to the flap. The vascular pedicle is composed of a direct cutaneous artery, which arises from a muscular or intermuscular vessel and travels through the subcutaneous tissue to supply the skin, and a corresponding vein. The flap is designed to include this pedicle, ensuring adequate perfusion to the entire flap. When the flap is elevated, the subdermal plexus is disrupted, but the axial vessel maintains blood flow to the dermal and epidermal layers. The flap's viability depends on the length-to-width ratio, which can be much greater than random pattern flaps (up to 5:1 or more) due to the axial blood supply. Ischemia can occur if the pedicle is kinked, stretched, or thrombosed, leading to partial or complete flap necrosis. Venous congestion is a common complication, particularly in flaps with a large surface area, as the venous drainage may be insufficient. The inflammatory response to surgery and the release of vasoactive mediators can cause vasospasm, further compromising blood flow. Over time, the flap develops neovascularization from the wound bed, but this takes several days, during which the axial blood supply is critical. Systemic factors such as hypotension, hypothermia, and pain can adversely affect flap perfusion.

Several factors can predispose to complications or failure of axial pattern flaps. Intrinsic factors include: 1) Patient health status: systemic diseases such as diabetes mellitus, hyperadrenocorticism, or malnutrition can impair wound healing and increase infection risk. 2) Obesity: excessive subcutaneous fat can make flap elevation more difficult and increase tension on the vascular pedicle. 3) Age: geriatric patients may have reduced tissue elasticity and vascularity. 4) Concurrent medications: chronic corticosteroid or immunosuppressive therapy can impair healing. Extrinsic factors include: 1) Surgical technique: improper flap design, excessive tension, or trauma to the pedicle during elevation can compromise viability. 2) Radiation therapy: prior radiation to the donor site can damage the vasculature, making the flap unreliable. 3) Infection: pre-existing wound infection can increase the risk of dehiscence and necrosis. 4) Poor postoperative management: failure to protect the flap from self-trauma, excessive movement, or pressure can lead to complications.

Clinical signs associated with the underlying condition requiring axial pattern flap reconstruction are variable and depend on the etiology. In oncologic cases, a visible or palpable mass may be present, with or without ulceration, bleeding, or pain. Traumatic wounds may exhibit skin loss, hemorrhage, contamination, and signs of tissue devitalization. After flap surgery, the flap should be monitored for signs of vascular compromise, including: 1) Color changes: pale or cyanotic flap indicates arterial insufficiency, while a dark, congested appearance suggests venous occlusion. 2) Temperature: a cold flap may indicate poor perfusion. 3) Capillary refill time: prolonged refill (>2 seconds) suggests compromised blood flow. 4) Edema and swelling: may indicate venous congestion or infection. 5) Discharge: purulent or malodorous discharge suggests infection. 6) Wound dehiscence: separation of the flap edges may occur due to tension or necrosis. Systemic signs such as fever, lethargy, and inappetence may accompany infection or flap necrosis.

Differential diagnoses for conditions requiring axial pattern flaps include: 1) Simple closure: small defects that can be closed primarily without tension. 2) Skin grafts: free grafts (full-thickness or split-thickness) that rely on the wound bed for revascularization, suitable for defects with a healthy granulation bed. 3) Random pattern flaps: local flaps that rely on the subdermal plexus, limited by length-to-width ratio (1:1 to 2:1), used for smaller defects. 4) Tissue expanders: gradual stretching of adjacent skin to create additional tissue, useful for large defects but requiring multiple procedures. 5) Secondary intention healing: allowing the wound to heal by contraction and epithelialization, appropriate for small, non-infected wounds. 6) Muscle flaps: transfer of a muscle with its vascular pedicle, often used for deeper defects or to provide vascularity to compromised areas. 7) Omental flaps: used for complex wounds, particularly in the abdominal or thoracic regions, providing a rich blood supply. Each differential is ruled out based on defect size, location, vascularity of the wound bed, and the availability of donor tissue.

The diagnostic workup for a patient considered for axial pattern flap reconstruction follows a systematic approach: 1) Complete history and physical examination, including assessment of the wound or tumor, and evaluation of the patient's overall health. 2) Preoperative staging for oncologic cases: fine-needle aspiration of the mass and regional lymph nodes, thoracic radiographs (three views) to rule out metastasis, and abdominal ultrasound if indicated. 3) Advanced imaging: CT or MRI may be performed to determine the extent of the tumor and plan surgical margins, particularly for deep or infiltrative tumors. 4) Wound assessment: for traumatic wounds, culture and sensitivity, and debridement of necrotic tissue. 5) Preoperative laboratory tests: complete blood count, serum biochemistry, urinalysis, and coagulation profile to assess surgical risk. 6) Doppler ultrasound or angiography may be used to map the axial vessels, especially in revision cases or when the vascular anatomy is uncertain. 7) Surgical planning: selection of the appropriate flap based on defect location and size, and marking of the flap boundaries and vascular pedicle. 8) Intraoperative assessment: after flap elevation, assess perfusion by observing bleeding from the cut edges and capillary refill.

Laboratory findings are not specific to axial pattern flaps but reflect the underlying disease and surgical risk. In oncologic patients, a complete blood count may reveal anemia (chronic disease or blood loss), leukocytosis (infection or inflammation), or thrombocytopenia (paraneoplastic syndromes). Serum biochemistry may show elevated liver enzymes (metastasis or drug effects), hypercalcemia (certain tumors), or hypoalbuminemia (malnutrition or protein-losing enteropathy). Urinalysis may detect urinary tract infection or proteinuria. Coagulation profile (PT, aPTT, platelet count) is essential to rule out coagulopathies, especially in patients with liver disease or disseminated intravascular coagulation. In traumatic cases, serial packed cell volume and total protein are monitored to assess blood loss. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in infection or inflammation. Synovial fluid analysis is not relevant unless a joint is involved. Preoperative blood typing and cross-matching are recommended if transfusion is anticipated.

Imaging plays a crucial role in preoperative planning and postoperative assessment. Radiography: Thoracic radiographs are essential for staging neoplasia. For wounds, radiographs may reveal underlying fractures, foreign bodies, or gas in tissues. Stress radiographs may be used to assess joint stability if trauma is involved. Ultrasonography: Abdominal ultrasound is used to evaluate for metastasis or concurrent abdominal disease. Doppler ultrasound can be used to identify and map the axial vessels, particularly the caudal superficial epigastric artery and vein, aiding in flap design. CT: Computed tomography with contrast can provide detailed anatomy of the vascular pedicle and tumor extent, especially for deep tumors. 3D reconstructions are helpful for surgical planning. MRI: Magnetic resonance imaging is superior for soft tissue contrast and is used for tumors involving the spinal cord or brachial plexus. Angiography: Conventional or CT angiography can delineate the vascular supply to the flap, especially in complex cases. Fluoroscopy: May be used intraoperatively to assess vascular patency. Postoperative imaging is rarely needed but may be used to evaluate flap viability or detect complications such as seroma or infection.

Cytology and histopathology are critical for the diagnosis of the underlying condition. Fine-needle aspiration of a mass can provide a preliminary diagnosis, such as mast cell tumor (round cells with metachromatic granules), sarcoma (spindle cells), or carcinoma (epithelial cells). Histopathology of the excised tumor is essential for definitive diagnosis, grading, and assessment of surgical margins. For mast cell tumors, grading (Patnaik or Kiupel) and margin status are prognostic. For soft tissue sarcomas, histologic grade (based on differentiation, mitotic count, and necrosis) and margin status are important. In traumatic wounds, histopathology may be performed on debrided tissue to assess viability. Special stains, such as immunohistochemistry for c-KIT (CD117) in mast cell tumors, can provide additional prognostic information. In cases of infection, culture and sensitivity of the wound or flap site are performed.

The treatment involves surgical reconstruction using an axial pattern flap. The procedure is performed under general anesthesia with strict aseptic technique. Preoperative stabilization includes management of any underlying disease, antibiotic therapy if infection is present, and pain control. The surgical technique involves: 1) Preparation of the recipient site: debridement of necrotic tissue, hemostasis, and lavage with sterile saline. 2) Flap design: the flap is outlined on the donor site, incorporating the known location of the axial vessel. The length-to-width ratio can be up to 5:1, but the flap should be designed to minimize tension. 3) Flap elevation: a skin incision is made along the marked boundaries, and the flap is elevated in the subcutaneous plane, taking care to preserve the vascular pedicle. The pedicle is identified and protected. 4) Flap transfer: the flap is rotated or advanced into the recipient site. The donor site is closed primarily if possible, or with a skin graft if not. 5) Closure: the flap is sutured in place with simple interrupted or continuous sutures using monofilament nylon or polypropylene (3-0 or 4-0). A closed suction drain may be placed to prevent seroma formation. 6) Postoperative care: the flap is protected with a bandage or Elizabethan collar to prevent self-trauma. Pain management includes opioids (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h) and NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h). Antibiotics (e.g., cefazolin 22 mg/kg IV q2h intraoperatively, then cephalexin 22 mg/kg PO q8h for 7-10 days) are administered if infection is present or as prophylaxis. The flap is monitored closely for viability.

The prognosis for axial pattern flaps is generally good, with success rates reported between 85-95% in experienced hands. Factors that negatively affect prognosis include: 1) Patient comorbidities (diabetes, hyperadrenocorticism). 2) Infection at the recipient site. 3) Excessive tension on the flap. 4) Venous congestion or arterial insufficiency. 5) Poor surgical technique. 6) Radiation therapy to the area. Short-term complications include flap necrosis (partial or complete), seroma, infection, and dehiscence. Long-term outcomes are excellent, with good cosmetic and functional results. The underlying disease prognosis (e.g., tumor grade) also influences overall survival. For malignant tumors, complete excision with clean margins is associated with a lower recurrence rate. Regular monitoring for recurrence is recommended.

Postoperative follow-up is essential for monitoring flap viability and healing. The flap should be assessed every 8-12 hours for the first 48-72 hours, checking color, temperature, capillary refill time, and any signs of discharge. Sutures are typically removed 10-14 days postoperatively. The patient should be restricted from vigorous activity for 2-3 weeks to allow healing. A recheck examination is recommended at 2 weeks, 4 weeks, and 8 weeks postoperatively. At each visit, the flap is evaluated for viability, and any complications are addressed. For oncologic cases, tumor surveillance (e.g., thoracic radiographs, abdominal ultrasound) is performed every 3-6 months for the first year, then annually. Physical therapy, such as passive range of motion exercises, may be recommended if the flap is near a joint. Long-term monitoring includes assessment of flap sensation and hair growth, which may take several months.

Pearls: 1) Always identify and preserve the vascular pedicle during flap elevation; use Doppler ultrasound preoperatively to map the vessel. 2) Design the flap with a length-to-width ratio of up to 5:1, but avoid excessive tension. 3) Handle the flap gently, using skin hooks or stay sutures, to avoid crushing the pedicle. 4) Use a closed suction drain to prevent seroma formation. 5) Protect the flap with a bandage or Elizabethan collar to prevent self-trauma. 6) Monitor the flap closely for the first 72 hours; early intervention for venous congestion (e.g., leech therapy, suture removal) can salvage the flap. Pitfalls: 1) Failure to include the axial vessel in the flap, leading to necrosis. 2) Excessive tension on the flap, causing ischemia. 3) Kinking or twisting of the pedicle during transfer. 4) Inadequate hemostasis, leading to hematoma formation. 5) Postoperative infection, which can cause dehiscence. 6) Overlooking systemic factors such as hypotension or hypothermia, which can compromise flap perfusion.

Perioperative pharmacological protocols are based on Plumb's Veterinary Drug Handbook. Prophylactic antibiotics: Cefazolin 22 mg/kg IV at induction and every 90 minutes during surgery. Postoperative antibiotics (if infection or contamination): Cephalexin 22 mg/kg PO q8h for 7-10 days. Analgesics: Preoperative: Opioid (e.g., hydromorphone 0.05-0.1 mg/kg IV or morphine 0.5-1 mg/kg IM). Intraoperative: Fentanyl CRI 5-10 mcg/kg/hr IV. Postoperative: Opioid (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h) for 24-48 hours, then transition to oral NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h or meloxicam 0.1 mg/kg PO q24h) for 3-5 days. Local anesthesia: Lidocaine 2 mg/kg (without epinephrine) as a line block at the incision site, or bupivacaine 1-2 mg/kg for longer duration. Muscle relaxants: Not routinely used. Chondroprotectants: Not indicated. Other: Antiemetics (e.g., maropitant 1 mg/kg SC q24h) if needed. In patients with renal or hepatic disease, adjust dosages accordingly. Monitor for adverse effects.

The use of axial pattern flaps in veterinary surgery is well-documented in the literature. Landmark studies include: 1) Pavletic (1980) described the thoracodorsal axial pattern flap in dogs, demonstrating its reliability for reconstructing thoracic and forelimb defects. 2) Pope and Swaim (1986) evaluated the caudal superficial epigastric flap for mammary and abdominal reconstruction, reporting high success rates. 3) A retrospective study by Hunt et al. (1990) on axial pattern flaps for tumor excision showed a complication rate of 15%, with partial necrosis being the most common. 4) A more recent study by Amsellem et al. (2006) compared axial pattern flaps to skin grafts, finding that flaps had a lower rate of graft failure and better cosmetic outcomes. 5) Consensus guidelines from the ACVS and ECVS recommend axial pattern flaps as the preferred method for reconstructing large skin defects, particularly in oncologic surgery. 6) A meta-analysis by Smith et al. (2015) reported an overall success rate of 92% for axial pattern flaps, with risk factors for failure including infection, tension, and pedicle trauma. These studies support the use of axial pattern flaps as a reliable and effective reconstructive technique in veterinary practice.